KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Shares Issued (2016 - 2025)

Charles River Laboratories International has reported Shares Issued over the past 16 years, most recently at $711000.0 for Q4 2025.

  • Quarterly results put Shares Issued at $711000.0 for Q4 2025, down 7.42% from a year ago — trailing twelve months through Dec 2025 was $714000.0 (down 97.01% YoY), and the annual figure for FY2025 was $714000.0, down 97.01%.
  • Shares Issued for Q4 2025 was $711000.0 at Charles River Laboratories International, up from $2000.0 in the prior quarter.
  • Over the last five years, Shares Issued for CRL hit a ceiling of $21.5 million in Q1 2024 and a floor of $1000.0 in Q2 2025.
  • Median Shares Issued over the past 5 years was $3.9 million (2023), compared with a mean of $6.4 million.
  • Biggest five-year swings in Shares Issued: skyrocketed 216.51% in 2022 and later crashed 99.88% in 2025.
  • Charles River Laboratories International's Shares Issued stood at $2.3 million in 2021, then skyrocketed by 216.51% to $7.4 million in 2022, then dropped by 19.74% to $5.9 million in 2023, then tumbled by 87.07% to $768000.0 in 2024, then fell by 7.42% to $711000.0 in 2025.
  • The last three reported values for Shares Issued were $711000.0 (Q4 2025), $2000.0 (Q3 2025), and $1000.0 (Q2 2025) per Business Quant data.